Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-07-2828PMID 16269613PMCID PMC1895712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96.

  2011cited by this paper
• Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity

  2004cited by this paper
• Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.

  2004cited by this paper
• Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.

  2004cited by this paper
• High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.

  2004cited by this paper
• A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.

  2004cited by this paper
• Subsets of Memory Cytotoxic T Lymphocytes Elicited by Vaccination Influence the Efficiency of Secondary Expansion In Vivo

  2004cited by this paper
• Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

  2004cited by this paper
• Specific donor Vβ-associated CD4+ T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens

  2004cited by this paper
• Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses.

  2003cited by this paper
• IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

  2003cited by this paper
• Quantitative studies of CD8+ T-cell responses during microbial infection.

  2003cited by this paper
• The current status of hematopoietic cell transplantation.

  2003cited by this paper
• Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

  2002cited by this paper
• T cells require TRAIL for optimal graft-versus-tumor activity

  2002cited by this paper
• Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease.

  2002cited by this paper
• Cutting Edge: The Minor Histocompatibility Antigen H60 Peptide Interacts with Both H-2Kb and NKG2D1

  2002cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Cytolytic pathways in haematopoietic stem-cell transplantation

  2002cited by this paper
• Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

  2001cited by this paper
• Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.

  2001cited by this paper
• Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

  2001cited by this paper
• Quantitative Analysis of the Immune Response to Mouse Non-MHC Transplantation Antigens In Vivo: The H60 Histocompatibility Antigen Dominates Over All Others

  2001cited by this paper
• Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens.

  2000cited by this paper
• New Methods for Assessing T-Cell Responses

  2000cited by this paper
• Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

  1999cited by this paper
• Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.

  1998cited by this paper
• Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.

  1997cited by this paper
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996cited by this paper
• Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens.

  1996cited by this paper
• Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.

  1996cited by this paper
• Phenotypic Analysis of Antigen-Specific T Lymphocytes

  1996cited by this paper
• Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs.

  1980cited by this paper

• Th17 cells: a promising therapeutic target for Parkinson’s disease?

  2019cites this paper
• Impacts of the MHC class I-like XNC10 and innate-like T cells on tumor tolerance and rejection in the amphibian Xenopus.

  2019cites this paper
• Saporin-conjugated tetramers identify efficacious anti-HIV CD8+ T-cell specificities

  2017cites this paper
• Antigen-Specific Killer Polylactic-Co-Glycolic Acid (PLGA) Microspheres Can Prolong Alloskin Graft Survival in a Murine Model

  2015cites this paper
• for graft-versus-host disease Effective graft depletion of MiHAg T-cell specificities and consequences

  2013cites this paper
• Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology

  2013cites this paper
• Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.

  2012cites this paper
• Interrogating the repertoire: broadening the scope of peptide–MHC multimer analysis

  2011cites this paper
• Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation.

  2011cites this paper
• Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system?

  2011cites this paper
• Optimisation of T cell receptor antigen recognition for targeting disease

  2011cites this paper
• Novel immunotherapeutical strategies in allogeneic hematopoietic stem cell transplantation

  2010cites this paper
• T‐cell reconstitution without T‐cell immunopathology in two models of T‐cell‐mediated tissue destruction

  2009cites this paper
• Tricks with tetramers: how to get the most from multimeric peptide–MHC

  2009cites this paper
• Clinical Significance of Minor Histocompatibility Antigens in Allogeneic Stem Cell Transplantation

  2007cites this paper
• Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease.

  2007cites this paper
• A Single Minor Histocompatibility Antigen Encoded by UGT2B17 and Presented by Human Leukocyte Antigen-A*2902 and -B*4403

  2007cites this paper